The medical world is witnessing a remarkable shift in glucose management with the arrival of GLP-1 transdermal devices. These systems offer a potentially more convenient alternative to subcutaneous administrations of GLP-1 receptor agonists, minimizing the requirement of daily needle pokes. The technology administers the drug directly through th… Read More